Entry Detail


General Information

Database ID:exR0726317
RNA Name:ACOT7
RNA Type:mRNA
Chromosome:chr1
Starnd:-
Coordinate:
Start Site(bp):6264269End Site(bp):6394391
External Links:ENSG00000097021



Disease Information

Disease Name:Bladder Cancer
Disease Category:Cancers
MeSH ID:D001749
Type:Neoplasms/Urogenital Neoplasms
Alias:Urinary Bladder Neoplasms//Neoplasm, Urinary Bladder//Urinary Bladder Neoplasm//Neoplasms, Bladder//Bladder Neoplasms//Bladder Neoplasm//Neoplasm, Bladder//Bladder Tumors//Bladder Tumor//Tumor, Bladder//Tumors, Bladder//Urinary Bladder Cancer//Cancer, Urinary Bladder//Malignant Tumor of Urinary Bladder//Cancer of the Bladder//Bladder Cancer//Bladder Cancers//Cancer, Bladder//Cancer of Bladder



Expression Detail

GEO ID:GSE51843
Description:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer
Experimental Design:Cancer vs Control
Case Disease Type:Bladder Cancer
Case Disease SubType:NA
Case Sample:Bladder Cancer
Control Sample:Control
Number of Case:5
Number of Control:6
Number of Samples:11





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
HMGA1
chr6
34236873
34246231
+
CHAMP1
chr13
114314482
114337626
+
ANKZF1
chr2
219229783
219236679
+
PRR7
chr5
177446445
177456286
+
PGS1
chr17
78378649
78425114
+
GYPC
chr2
126656133
126696667
+
UBP1
chr3
33388336
33441371
-
TRIP10
chr19
6737925
6751530
+
MTRNR2L11
chr1
237943724
237945275
-
CCT7
chr2
73233420
73253021
+
SEMA7A
chr15
74409289
74433958
-
TLE3
chr15
70047790
70098176
-
GJA1
chr6
121435595
121449727
+
NAP1L1
chr12
76036585
76084958
-
UBE2D2
chr5
139526431
139628434
+
PPP6R1
chr19
55229779
55259017
-
CUL4A
chr13
113208193
113267108
+
EPB41L3
chr18
5392381
5630700
-
FXR1
chr3
180868141
180982753
+
CSNK2A1
chr20
472498
543835
-
ELP2
chr18
36129444
36180557
+
OGT
chrX
71533104
71575892
+
EEF2
chr19
3976056
3985463
-
MLYCD
chr16
83899115
83951445
+
ZNF675
chr19
23525631
23687220
-
SHC1
chr1
154962298
154974395
-
SLC25A6
chrX
1386152
1392113
-
ZNF333
chr19
14689801
14733746
+
RBM15B
chr3
51391285
51397908
+
TRIM11
chr1
228393673
228406835
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-155-5p
chr21
25573983
25574006
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC116407.1
chr17
32141226
32143135
-
AL117378.1
chr6
131901963
131920565
+
AC009119.2
chr16
83929796
83931223
-
AL139393.2
chr6
160926269
160943110
+
DANCR
chr4
52712404
52720351
+
FGD5-AS1
chr3
14920347
14948424
-
MIR155HG
chr21
25561909
25575168
+
TUG1
chr22
30969245
30979395
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:24458310
Title:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer.
Author:Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Zorroza K,Mosen-Ansorena D, Gonzalez E, Aransay AM, Falcon-Perez JM, Unda-Urzaiz M, Royo F.
Journal:Cancers (Basel). 2014 Jan 22;6(1):179-92.
Description:LASS2 and GALNT1 were present in cancer patients, while ARHGEF39 and FOXO3 were found only in non-cancer urinary vesicles, which could be diagnostic markers for bladder cancer.